VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
In 2008, three years after Natalie Hayden was diagnosed with Crohn’s disease, she was hospitalized with an abscess the size of a tennis ball in her small intestine. Until then, Hayden had been ...
Blue Cross Blue Shield of Oklahoma (BCBS), including BCBS plans in states of Illinois, New Mexico, Texas and Montana, is requiring patients insured with them who have severe asthma to inject ...
– Survey findings showed a majority of participants had a favorable experience injecting Acthar Gel via SelfJect, with a high level of satisfaction, confidence, convenience, and ease of use regarding ...
OKLAHOMA CITY (KFOR) — Next month, Oklahomans with severe asthma who are insured with BlueCross and BlueShield of Oklahoma (BCBSOK), may have to give themselves life-saving shots at home after a ...
Please provide your email address to receive an email when new articles are posted on . Fears associated with needles may cause patients and caregivers to delay their use of epinephrine autoinjectors.
Nearly 60% of patients with adrenal insufficiency and their caregivers needed to administer emergency glucocorticoid injections, yet more than one third failed, resulting in negative outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback